Attempted Suicide with Enalapril
- 17 July 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (3) , 197
- https://doi.org/10.1056/nejm198607173150319
Abstract
To the Editor: Enalapril (MK-421; ethyl ester of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline) is a long-acting inhibitor of angiotensin-converting enzyme that is used in the treatment of hypertension.1 The drug appears to be safe in the usual doses. However, we recently saw a patient who attempted to commit suicide by ingesting large doses of enalapril and warfarin.The patient was a 56-year-old woman who had had a mitral-valve replacement and had congestive cardiac failure since 1982. Enalapril (5 mg) was added to her drug regimen of spironolactone (100 mg daily), furosemide (80 mg twice daily), warfarin (2 mg daily), and digoxin (0.125 mg daily). . . .Keywords
This publication has 4 references indexed in Scilit:
- Inhibitor binding assay for angiotensin-converting enzyme.Clinical Chemistry, 1984
- Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.British Journal of Clinical Pharmacology, 1982
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981